mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.08 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.09 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.09 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.09 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.3 |
0.09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.09 |